Acadia Healthcare (NASDAQ:ACHC) PT Set at $28.00 by Royal Bank Of Canada

Acadia Healthcare (NASDAQ:ACHC) received a $28.00 price target from investment analysts at Royal Bank Of Canada in a research report issued to clients and investors on Wednesday, Marketbeat.com reports. The brokerage currently has an “outperform” rating on the stock. Royal Bank Of Canada’s price objective indicates a potential upside of 34.81% from the company’s previous close.

A number of other equities research analysts also recently issued reports on the stock. Guggenheim reduced their price objective on shares of Acadia Healthcare from $36.00 to $29.00 and set a “buy” rating on the stock in a research note on Thursday, August 7th. Cowen reiterated a “buy” rating on shares of Acadia Healthcare in a research note on Thursday, August 7th. Mizuho reduced their price objective on shares of Acadia Healthcare from $37.00 to $32.00 and set a “neutral” rating on the stock in a research note on Wednesday, May 14th. Wall Street Zen upgraded shares of Acadia Healthcare from a “sell” rating to a “hold” rating in a research note on Sunday, August 3rd. Finally, UBS Group dropped their target price on shares of Acadia Healthcare from $45.00 to $31.00 and set a “buy” rating for the company in a report on Thursday, August 7th. Five investment analysts have rated the stock with a hold rating and eight have assigned a buy rating to the stock. Based on data from MarketBeat.com, Acadia Healthcare has a consensus rating of “Moderate Buy” and a consensus price target of $42.25.

Acadia Healthcare Trading Up 2.2%

ACHC stock opened at $20.77 on Wednesday. The company has a debt-to-equity ratio of 0.73, a quick ratio of 1.32 and a current ratio of 1.32. The company’s 50-day simple moving average is $22.05 and its 200 day simple moving average is $27.38. Acadia Healthcare has a 52 week low of $17.13 and a 52 week high of $82.40. The company has a market capitalization of $1.92 billion, a PE ratio of 13.76, a price-to-earnings-growth ratio of 3.96 and a beta of 0.88.

Acadia Healthcare (NASDAQ:ACHC) last announced its quarterly earnings data on Tuesday, August 5th. The company reported $0.83 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.71 by $0.12. The firm had revenue of $869.23 million for the quarter, compared to the consensus estimate of $839.59 million. Acadia Healthcare had a net margin of 4.31% and a return on equity of 8.34%. The business’s revenue for the quarter was up 9.2% on a year-over-year basis. During the same period in the prior year, the company posted $0.91 earnings per share. As a group, sell-side analysts anticipate that Acadia Healthcare will post 3.38 earnings per share for the current year.

Institutional Inflows and Outflows

A number of large investors have recently added to or reduced their stakes in ACHC. Allworth Financial LP raised its holdings in Acadia Healthcare by 676.4% in the 2nd quarter. Allworth Financial LP now owns 1,351 shares of the company’s stock valued at $31,000 after buying an additional 1,177 shares during the last quarter. EverSource Wealth Advisors LLC raised its holdings in Acadia Healthcare by 54.8% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 1,404 shares of the company’s stock valued at $32,000 after buying an additional 497 shares during the last quarter. UMB Bank n.a. raised its holdings in Acadia Healthcare by 149.5% in the 1st quarter. UMB Bank n.a. now owns 1,260 shares of the company’s stock valued at $38,000 after buying an additional 755 shares during the last quarter. Caitong International Asset Management Co. Ltd raised its holdings in Acadia Healthcare by 11,218.2% in the 1st quarter. Caitong International Asset Management Co. Ltd now owns 1,245 shares of the company’s stock valued at $38,000 after buying an additional 1,234 shares during the last quarter. Finally, State of Wyoming bought a new position in Acadia Healthcare in the 4th quarter valued at approximately $56,000.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.